Skip to main content
Year archive

BioArctic — 2018 filings

All 63 regulatory filings released by BioArctic (BIOA) in 2018, sourced directly from the official regulator.

63 Filings
2018 Period
2018 filings (63)
Filing Released Lang
BioArctic outlicenses its alpha-synuclein antibody portfolio for Parkinson’s Disease to AbbVie after receiving clearance
Capital/Financing Update
2018-12-14 English
BioArctic utlicensierar sin portfölj med antikroppar mot alfa-synuklein för Parkinsons sjukdom till AbbVie efter godkänd konkurrensprövning
Capital/Financing Update
2018-12-14 Swedish
BioArctic is awarded grant from EU’s Horizon 2020 for participation in research consortium for better diagnostic tools and biomarkers for Parkinson’s
Regulatory Filings
2018-11-12 English
BioArctic får anslag från EU:s Horizon 2020 för deltagande i forskningskonsortium för bättre diagnostiska verktyg och biomarkörer för Parkinsons
Regulatory Filings
2018-11-12 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-08 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-08 English
BioArctic presents Nomination Committee and publishes financial calendar 2019
AGM Information
2018-11-06 English
BioArctic presenterar valberedning och offentliggör finansiell kalender 2019
AGM Information
2018-11-06 Swedish
BioArctic’s partner AbbVie exercises its option to license the alpha-synuclein antibody portfolio for Parkinson’s Disease
Capital/Financing Update
2018-11-02 English
BioArctics partner AbbVie utövar sin option att licensiera portföljen med alfa-synukleinantikroppar för Parkinsons sjukdom
Capital/Financing Update
2018-11-02 Swedish
BioArctic announces additional BAN2401 Phase 2b study results in early Alzheimer’s disease presented by Eisai at the 2018 CTAD conference
Earnings Release FY 2018
2018-10-25 English
BioArctic meddelar ytterligare resultat från Fas 2b-studien med BAN2401 i tidig Alzheimers sjukdom presenterade av Eisai på CTAD-konferensen 2018
Earnings Release FY 2018
2018-10-25 Swedish
BioArctic får beviljat konceptpatent i Europa för bolagets strategi för sjukdomsmodifierande behandling av Parkinsons sjukdom
Regulatory Filings
2018-10-21 Swedish
BioArctic is granted a concept patent in Europe for the company’s strategy for disease-modifying treatment of Parkinson’s disease
Regulatory Filings
2018-10-21 English
BioArctic får patentskydd i Europa för en medicinteknisk produkt för behandling av patienter med komplett ryggmärgsskada
Regulatory Filings
2018-10-03 Swedish
BioArctic receives European patent protection for a medical device for treatment of patients with Complete Spinal Cord Injury
Regulatory Filings
2018-10-03 English
BioArctic ingår forskningssamarbete med Brain Biomarker Solutions in Gothenburg AB för utveckling av ny diagnostik för Alzheimers sjukdom
Regulatory Filings
2018-09-13 Swedish
BioArctic signs a research agreement with Brain Biomarker Solutions in Gothenburg AB to develop new diagnostics for Alzheimer’s disease
Regulatory Filings
2018-09-13 English
BioArctic utvidgar forskningssamarbetet med Uppsala universitet kring antikroppsbaserad bilddiagnostik av hjärnan hos Alzheimerpatienter
Regulatory Filings
2018-09-03 Swedish
BioArctic expands the research collaboration with Uppsala University concerning antibody-based diagnostic imaging of the brain in Alzheimer patients
Regulatory Filings
2018-09-03 English
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-23 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-23 English
Invitation to presentation of BioArctic’s Interim Report for the period January – June 2018 on August 23, 2018
Report Publication Announcement
2018-08-14 English
Inbjudan till presentation av BioArctics delårsrapport för perioden januari – juni 2018 den 23 augusti 2018
Report Publication Announcement
2018-08-14 Swedish
BioArctic obtains exclusive rights to develop antibody treatments for Alzheimer’s disease from a research project jointly owned with Eisai
Regulatory Filings
2018-08-07 English
BioArctic erhåller exklusiva rättigheter till att utveckla antikroppsbehandlingar för Alzheimers sjukdom från ett forskningsprojekt samägt med Eisai
Regulatory Filings
2018-08-07 Swedish
BioArctic meddelar detaljerade resultat från Fas 2b-studien med BAN2401 i tidig Alzheimers sjukdom som rapporterats vid AAIC 2018
Earnings Release FY 2018
2018-07-25 Swedish
BioArctic announces detailed results of the BAN2401 Phase 2b study in early Alzheimer’s disease presented at AAIC 2018
Earnings Release FY 2018
2018-07-25 English
BioArctic: Late breaking Phase 2b study results of BAN2401 in Alzheimer’s disease will be webcast live from AAIC 2018 by Eisai
Regulatory Filings
2018-07-18 English
BioArctic: Senaste resultat från BAN2401 Fas 2b-studien i Alzheimer patienter kommer att sändas via Eisais webcast från AAIC 2018
Regulatory Filings
2018-07-18 Swedish
BioArctic receives regulatory approval in Finland for a clinical study in patients with Complete Spinal Cord Injury
Regulatory Filings
2018-07-10 English
BioArctic får myndighetsgodkännande i Finland för klinisk studie med patienter som har komplett ryggmärgsskada
Regulatory Filings
2018-07-10 Swedish
BioArctic announces positive topline results of BAN2401 Phase 2b at 18 months in early Alzheimer’s Disease
Regulatory Filings
2018-07-06 English
BioArctic meddelar positiva 18 månaders resultat i Fas 2b-studien med BAN2401 i tidig Alzheimers sjukdom
Earnings Release FY 2018
2018-07-06 Swedish
BioArctic announces changes in the Management Team effective September 1, 2018
Board/Management Information
2018-06-27 English
BioArctic meddelar förändringar i ledningsgruppen per den 1 september 2018
Board/Management Information
2018-06-27 Swedish
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I BIOARCTIC (PUBL)
AGM Information
2018-05-15 Swedish
REPORT FROM THE ANNUAL GENERAL MEETING IN BIOARCTIC AB (PUBL)
AGM Information
2018-05-15 English
BioArctic utvidgar forskningssamarbetet med Uppsala universitet kring ny antikroppsteknologi
Regulatory Filings
2018-05-14 Swedish
BioArctic extends the research collaboration with Uppsala University regarding new antibody technology
Regulatory Filings
2018-05-14 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-26 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-26 English
Inklusionen av patienter med komplett ryggmärgsskada till den första panelen av BioArctics pågående studie har slutförts
Regulatory Filings
2018-04-25 Swedish
Inclusion completed of patients with complete spinal cord injury in the first panel of BioArctic’s ongoing study
Regulatory Filings
2018-04-25 English
Annual Report 2017
Annual Report FY 2017
2018-04-24 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-24 English
NOTICE OF ANNUAL GENERAL MEETING IN BIOARCTIC AB (PUBL)
AGM Information
2018-04-13 English
KALLELSE TILL ÅRSSTÄMMA I BIOARCTIC AB (PUBL)
AGM Information
2018-04-13 Swedish
Inbjudan till presentation av BioArctics delårsrapport januari – mars 2018 den 26 april 2018
Report Publication Announcement
2018-04-12 Swedish
Invitation to presentation of BioArctic’s Interim Report January – March 2018 on April 26, 2018
Report Publication Announcement
2018-04-12 English
BioArctic får myndighetsgodkännande i Norge för klinisk studie med patienter som har komplett ryggmärgsskada
Regulatory Filings
2018-03-21 Swedish
BioArctic receives regulatory approval in Norway for a clinical study in patients with Complete Spinal Cord Injury
Regulatory Filings
2018-03-21 English
BioArctic får patentskydd i Japan för en medicinteknisk produkt för behandling av patienter med komplett ryggmärgsskada
Regulatory Filings
2018-03-19 Swedish
BioArctic receives patent protection in Japan for a medical device for treatment of patients with Complete Spinal Cord Injury
Regulatory Filings
2018-03-19 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-03-09 English
BioArctic receives regulatory approval in Estonia for a clinical study in patients with Complete Spinal Cord Injury
Regulatory Filings
2018-02-21 English
BioArctic får myndighetsgodkännande i Estland för klinisk studie med patienter som har komplett ryggmärgsskada
Regulatory Filings
2018-02-21 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report FY 2017
2018-02-20 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report FY 2017
2018-02-20 English
Invitation to presentation of BioArctic’s Full Year Report 2017 on February 20, 2018
Report Publication Announcement
2018-02-05 English
Inbjudan till presentation av BioArctics bokslutskommuniké 2017 den 20 februari 2018
Report Publication Announcement
2018-02-05 Swedish
BioArctic får patentskydd i USA för en metod med en medicinteknisk produkt för behandling av patienter med komplett ryggmärgsskada
Regulatory Filings
2018-02-02 Swedish
BioArctic receives US patent protection for a method with a medical device for treatment of patients with Complete Spinal Cord Injury
Regulatory Filings
2018-02-02 English